Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Shin Kong Wu Ho-Su Memorial Hospital clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Taiwan register with Shin Kong Wu Ho-Su Memorial Hospital as lead sponsor. Synced 15 Nov 2026
11Current trials
8Recruiting now
1Drug in these trials
1Trial register
At a glance

Shin Kong Wu Ho-Su Memorial Hospital is the lead sponsor of 11 current clinical trials in our Taiwan register. 8 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Colchicine. The most-studied condition is Chronic Limb-Threatening Ischemia.

ClinicalTrials.gov trials by status

  • Recruiting873%
  • Not yet open327%

Trials by phase

  • Not applicable982%
  • Phase 319%
  • Observational19%
01

Clinical trials sponsored by Shin Kong Wu Ho-Su Memorial Hospital

11 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Is Adding Extracorporeal Shock Wave Therapy to Physiotherapy and Corticosteroid Injection Beneficial for Frozen Shoulder
NCT06491745 · ClinicalTrials.gov ↗ · Frozen Shoulder, Corticosteroid Injection, Physical Therapy
Not applicable Recruiting 2024-08 Taiwan
Colchicine in Chronic Limb-Threatening Ischemia
NCT07536373 · ClinicalTrials.gov ↗ · Chronic Limb-Threatening Ischemia
Phase 3 Recruiting 2026-06 Taiwan
Comparative Efficacy of Intra-articular vs. MRI-guided Extra-articular Dextrose Injections in Knee Osteoarthritis Management
NCT06755697 · ClinicalTrials.gov ↗ · Knee Osteoarthritis, Glucose, Prolotherapy
Not applicable Recruiting 2025-01 Taiwan
Pulse Wave Velocity and in Subacute Stroke Patients Following Rehabilitation
NCT06224517 · ClinicalTrials.gov ↗ · Ischemic Stroke, Arterial Stiffness, Pulse Wave Velocity
Observational Recruiting 2024-02 Taiwan
Efficacy of Combining Ultrasound-Guided Needle Release of Transverse Carpal Ligament and Median Nerve Dextrose Water Hydrodissection for Carpal Tunnel Syndrome
NCT07324005 · ClinicalTrials.gov ↗ · Carpal Tunnel Syndrome, Dextrose, Carpal Tunnel Release
Not applicable Recruiting 2026-01 Taiwan
Ultrasound Guided Transcutaneous Pulsed Radiofrequency for Cervical Radiculopathy
NCT07207356 · ClinicalTrials.gov ↗ · Cervical Radiculopathy
Not applicable Recruiting 2025-11 Taiwan
The Efficacy of Transcutaneous Pulsed Radiofrequency Acupuncture for Knee Osteoarthritis
NCT06702046 · Osteoarthritis (OA) of the Knee
Not applicable Recruiting 2025-02 Taiwan
Comparison of Transcatheter Arterial Microembolization and Corticosteroid Injection and for Treatment of Frozen Shoulder
NCT07696923 · ClinicalTrials.gov ↗ · Frozen Shoulder, Chronic Pain, Adhesive Capsulitis
Not applicable Recruiting 2026-08 Taiwan
IVUS Guidance in BTK Interventions
NCT07731997 · ClinicalTrials.gov ↗ · Chronic Limb-Threatening Ischemia
Not applicable Not yet open 2026-08 Taiwan
Effects of Hyaluronic Acid for Subdeltoid Bursitis
NCT07729527 · ClinicalTrials.gov ↗ · Subdeltoid Bursitis of the Shoulder
Not applicable Not yet open 2026-07 Taiwan
Continuous Passive Motion to Prevent Ankle Contracture and Muscle Atrophy in Ventilated Patients
NCT07032051 · ClinicalTrials.gov ↗ · Ankle Contracture, Critically Ill Intensive Care Unit Patients, Muscle Atrophy
Not applicable Not yet open 2025-06 Taiwan

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Shin Kong Wu Ho-Su Memorial Hospital trials

1 compound

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Shin Kong Wu Ho-Su Memorial Hospital trials

26 conditions
Chronic Limb-Threatening Ischemia2Frozen Shoulder2Corticosteroid Injection1Physical Therapy1Extracorporeal Shock Wave Therapy1Subdeltoid Bursitis of the Shoulder1Knee Osteoarthritis1Glucose1Prolotherapy1MRI1Ischemic Stroke1Arterial Stiffness1Pulse Wave Velocity1Rehabilitation1Ankle Contracture1Critically Ill Intensive Care Unit Patients1Muscle Atrophy1Carpal Tunnel Syndrome1Dextrose1Carpal Tunnel Release1Ultrasound1Cervical Radiculopathy1Osteoarthritis (OA) of the Knee1Chronic Pain1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in Taiwan118

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Chronic Limb-Threatening Ischemia

SponsorTrials
R3 Vascular1
Cardiovascular and Interventional Radiological Society of Europe1

Sponsors with the most current trials registered for this condition.

06

Questions about Shin Kong Wu Ho-Su Memorial Hospital trials

How many clinical trials does Shin Kong Wu Ho-Su Memorial Hospital sponsor?

Shin Kong Wu Ho-Su Memorial Hospital is the lead sponsor of 11 current trials on ClinicalTrials.gov in our Taiwan register, as of the registry sync on 15 November 2026. Completed and withdrawn studies are not counted.

Are Shin Kong Wu Ho-Su Memorial Hospital trials recruiting?

Yes. 8 of its 11 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Shin Kong Wu Ho-Su Memorial Hospital testing?

Its current trials name 1 drug or biological as interventions. The most frequent are Colchicine (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 15 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.